Novo Nordisk | NVO - Net Income

Stock Price
43.35
Daily Change
-3.83 -8.12%
Monthly
-22.89%
Yearly
-50.26%
Q1 Forecast
56.42

Novo Nordisk reported DKK4.03B in Net Income for its fiscal quarter ending in June of 2025.





Net Income Change Date
ANI Pharmaceuticals USD 26.27M 18.13M Sep/2025
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Bausch Health Companies USD 179M 31M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Corcept Therapeutics USD 19.67M 15.48M Sep/2025
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
GlaxoSmithKline GBP 636M 1.38B Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Novartis USD 3.93B 96M Sep/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Novo Nordisk DKK 4.03B 25.01B Jun/2025
Pacira USD 5.43M 10.28M Sep/2025
Perrigo USD 7.5M 15.9M Sep/2025
Prestige Brands USD 46.7M 22.44M Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Zoetis USD 721M 3M Sep/2025